PRESS RELEASES More events are coming soon. Keyword Search Year: 2022202120202019201820172016201520142013 10/13/21 Summary Toggle TRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors Printer Friendly PDF Version 10/11/21 Summary Toggle TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001 Printer Friendly PDF Version 09/13/21 Summary Toggle TRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Printer Friendly PDF Version 09/07/21 Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Printer Friendly PDF Version 09/02/21 Summary Toggle TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference Printer Friendly PDF Version 08/11/21 Summary Toggle TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 08/09/21 Summary Toggle TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Printer Friendly PDF Version 08/03/21 Summary Toggle TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Printer Friendly PDF Version 07/28/21 Summary Toggle TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021 Printer Friendly PDF Version 07/21/21 Summary Toggle TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million Printer Friendly PDF Version Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
